Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal 
Sun Pharma announces $11.75 billion acquisition of Organon, enhancing its global footprint in women’s health and biosimilars.
27 Apr 04:01 · The Hindu
Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal 
Sun Pharma announces $11.75 billion acquisition of Organon, enhancing its global footprint in women’s health and biosimilars.
27 Apr 04:01 · The Hindu
last updated on 27 Apr 20:11